WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6601 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 1'7171 Child (under 5 years) mortality rate: 692

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 38'845  37'579  36'346  35'148  33'987  24'276  17'535  12'550 
Births 1'661  1'626  1'591  1'556  1'522  1'177  874  617 
Surviving infants 1'570  1'534  1'499  1'464  1'428  1'074  779  548 
Pop. less than 5 years 7'291  7'115  6'939  6'762  6'580  4'833  3'463  2'439 
Pop. less than 15 years 18'716  18'185  17'654  17'127  16'606  11'956  8'409  5'950 
Female 15-49 years 8'599  8'278  7'970  7'674  7'392  5'197  3'827  2'731 

Number of reported case

(Click for retrospective incidence data for Uganda)
Diphtheria 95  181 
Japanese encephalitis
Measles 314  7'878  2'027  3'312  1'313  42'554  2'637  13'415 
Mumps
Pertussis 913  2'122 
Polio* 28  37 
Rubella 291  7'878  2'027  3'312 
Rubella (CRS)
Tetanus (neonatal) 84  406  149  207  98  470  129 
Tetanus (total)** 1'358  2'928  1'019  623  1'822  710  288  48 
Yellow fever 32  66  106 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uganda)
Vaccine year result method % card seen                                                
BCG 2011  97  EPI   79  90  94  82  86  86  83  99* 
DTP1 2011  96  EPI   79  99  99*  89  91  87  72 
DTP3 2011  92  EPI   79  99  97  78  82  80  58  77 
DTP4         
IPV1         
HepB_BD         
HepB3 2004  76  EPI   73  99  97  78  82  80 
Hib3 2004  76  EPI   73  99  97  78  82  80 
JapEnc         
MCV1          96  97  82  75  73  61  74 
MCV2         
PCV1          96 
PCV3          50 
Pol3 2010  63  DHS   59  99  99  82  82  79  57  77 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  56  DHS   59  56  56  49  49  53  42  31 
PAB         
VAD1          55  24  59  58  56 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uganda)
BCG 93  93  93  97  86  82  75 
DTP1 89  89  89  91  87  80  72 
DTP3 78  78  78  82  80  52  45 
HepB3 78  78  78  82  80 
HepB_BD
Hib3 78  78  78  82  80 
MCV1 82  82  82  75  73  57  52 
MCV2
PAB 85  85  85  85  85  70  41 
PCV3 50 
Pol3 82  82  82  82  79  55  45 
Rota_last
YFV

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 14
From 50 to 79% 13
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; +4 weeks; +6 months; No From October 2015
IPV 14 weeks; Yes From October 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From July 2016
TT 15-45 years; +4 weeks;+6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2011-2014  2010-2014  2010 - 2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 112  55  39  80  80  80 

System performance

Total Nº districts in country number 112  112  112  112  80  80  80 
Nº districts with DTP3 coverage >=80% number 96  93  47  66  47  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 86  83  42  59  59  20 
Nº districts with measles (MCV1) coverage >=95% number 52  50  34  17  11  13   
% of districts with MCV1 coverage >=95% From 0 to 100% 46  45  30  15  14  16   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 49  24    100  21  21  60 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.